Product: CIDAL 2.25 g Injection

Brand Name: CIDAL 2.25 g
Content: Piperacillin and Tazobactam Injection I.P.
Company: Neon Laboratories Ltd
Pack: Vial

CIDAL 2.25 g Injection is a prescription broad-spectrum antibiotic containing a combination of Piperacillin (a penicillin-class antibiotic) and Tazobactam (a beta-lactamase inhibitor). It is used for the treatment of moderate to severe bacterial infections in hospital and clinical settings.

Tazobactam enhances the effectiveness of piperacillin by preventing bacterial resistance caused by beta-lactamase enzymes.

✨ Key Features

·         Active Ingredients:

o    Piperacillin I.P.

o    Tazobactam I.P.

·         Strength: 2.25 g (typically 2 g Piperacillin + 0.25 g Tazobactam)

·         Dosage Form: Sterile powder for injection

·         Administration: Intravenous (IV) infusion as directed by a physician

·         Prescription Required: Yes

�� Therapeutic Uses

CIDAL 2.25 g Injection is indicated for:

·         Lower respiratory tract infections

·         Urinary tract infections (UTI)

·         Intra-abdominal infections

·         Skin and soft tissue infections

·         Gynecological infections

·         Septicemia (bloodstream infections)

It works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death.

⚠️ Safety Information

·         To be administered only by a healthcare professional

·         Use cautiously in patients with penicillin allergy

·         Monitor kidney function during prolonged therapy

·         Possible side effects include diarrhea, rash, nausea, injection site reactions

·         Store below 30°C and protect from moisture

�� Category :- Antibiotic – Beta-lactam / Beta-lactamase Inhibitor Combination Injectable